Malawi Cancer Outcomes Research Program (M-CORP)

马拉维癌症结果研究计划 (M-CORP)

基本信息

  • 批准号:
    10223673
  • 负责人:
  • 金额:
    $ 26.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined. In 2018, there were more than 18 million new cancer cases and 9.5 million cancer deaths worldwide, and, by 2030, these numbers will increase by at least 50%. Countries with low or medium Human Development Index account for more than 60% of cancer cases and 70% of cancer deaths. Cancer deaths in sub-Saharan Africa occur disproportionately from cancers that are preventable and/or curable including lymphoma, cervical cancer and breast cancer. Addressing the substantial burden of cancer requires a new generation of cancer researchers who can test hypotheses in the African context. The University of North Carolina Project- Malawi (UNCPM) has a rich cancer research environment that includes participation in the National Cancer Institute (NCI) U54 consortium for HIV associated malignancies, the AIDS Malignancy Consortium, the International Epidemiologic Databases to Evaluate AIDS (IeDEA), NCI African Esophageal Cancer Consortium, and a USAID-funded cervical cancer screening study. To date, UNCPM has had significant success in cancer clinical trials and translational research projects, and in establishing a handful of early- career investigators, but momentum is needed to build on this foundation. First, large improvements in cancer control in Malawi require approaches that extend beyond clinical trials to cancer outcomes research, a broader approach that requires unique skills. At this time, there are few cancer researchers with both the necessary cancer research skills and the local experience to develop cancer outcomes solutions adapted to the Malawian context. Second, there is no defined pipeline for early-career cancer research capacity. Finally, there are few opportunities for successful Malawian investigators to obtain the additional skills and experience necessary to be competitive for independent research funding. To address these gaps, we propose to establish the Malawi Cancer Outcomes Research Program (M-CORP). This application is led by UNC in conjunction with the University of Malawi College of Medicine (COM) and in collaboration with other national and international institutions and training programs. M-CORP aims to increase the cadre of trained investigators who can pursue independent research careers by: 1) establishing a robust curriculum and training opportunities across the continuum of cancer outcomes research specific to the Malawian environment and research priorities; 2) supporting advanced degrees; and 3) overcoming obstacles to research independence by providing post- doctoral opportunities including mentored pilot grants. We will use a multi-PD leadership strategy based at both UNC and UNCPM that will optimize our strengths across the spectrum of cancer outcomes research. An exceptional pool of multidisciplinary mentors, a detailed plan for program evaluation, and robust, broad-based partnerships between UNC and Malawian institutions ensure that M-CORP objectives will be met and will establish Malawi as an internationally recognized center of excellence for cancer outcomes research.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lameck Chinula其他文献

Lameck Chinula的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lameck Chinula', 18)}}的其他基金

UNC CASCADE Network Research Base
UNC CASCADE网络研究基地
  • 批准号:
    10696082
  • 财政年份:
    2022
  • 资助金额:
    $ 26.9万
  • 项目类别:
UNC CASCADE Network Research Base
UNC CASCADE网络研究基地
  • 批准号:
    10543930
  • 财政年份:
    2022
  • 资助金额:
    $ 26.9万
  • 项目类别:
Malawi Cancer Outcomes Research Program (M-CORP)
马拉维癌症结果研究计划 (M-CORP)
  • 批准号:
    10613541
  • 财政年份:
    2021
  • 资助金额:
    $ 26.9万
  • 项目类别:
Malawi Cancer Outcomes Research Program (M-CORP)
马拉维癌症结果研究计划 (M-CORP)
  • 批准号:
    10402880
  • 财政年份:
    2021
  • 资助金额:
    $ 26.9万
  • 项目类别:
A novel cervical cancer screen-and-treat demonstration project with HPV self-testing and thermocoagulation for HIV-infected women in Malawi
针对马拉维感染艾滋病毒的妇女开展的新型宫颈癌筛查和治疗示范项目,包括 HPV 自检和热凝
  • 批准号:
    10020969
  • 财政年份:
    2019
  • 资助金额:
    $ 26.9万
  • 项目类别:

相似海外基金

NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
  • 批准号:
    6566071
  • 财政年份:
    2001
  • 资助金额:
    $ 26.9万
  • 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
  • 批准号:
    6423242
  • 财政年份:
    2000
  • 资助金额:
    $ 26.9万
  • 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
  • 批准号:
    6504219
  • 财政年份:
    2000
  • 资助金额:
    $ 26.9万
  • 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
  • 批准号:
    6303902
  • 财政年份:
    1999
  • 资助金额:
    $ 26.9万
  • 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
  • 批准号:
    6297230
  • 财政年份:
    1998
  • 资助金额:
    $ 26.9万
  • 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
  • 批准号:
    6263862
  • 财政年份:
    1998
  • 资助金额:
    $ 26.9万
  • 项目类别:
Search for specific modulators of the inflammatory resp onse in AIDS related cancer
寻找艾滋病相关癌症中炎症反应的特异性调节剂
  • 批准号:
    nhmrc : 960853
  • 财政年份:
    1996
  • 资助金额:
    $ 26.9万
  • 项目类别:
    CARG - Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了